Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Precision microbiome programming for therapeutic applications is limited by challenges in achieving reproducible colonic colonization. Previously, we created an exclusive niche that we used to engraft engineered bacteria into diverse microbiota in mice by using a porphyran prebiotic. Building on this approach, we have now engineered conditional attenuation into a porphyran-utilizing strain of by replacing native essential gene regulation with a porphyran-inducible promoter to allow reversible engraftment. Engineering a five-gene oxalate degradation pathway into the reversibly engrafting strain resulted in a therapeutic candidate that reduced hyperoxaluria, a cause of kidney stones, in preclinical models. Our phase 1/2a clinical trial demonstrated porphyran dose-dependent abundance and reversible engraftment in humans, reduction of oxalate in the urine, and characterized genetic stability challenges to achievinglong-term treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1126/science.adu8000 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Application Prospects and Challenges of Mesenchymal Stem Cell-Derived Exosomes in Spinal Cord Injury Repair.
Curr Stem Cell Res Ther
August 2025
Spinal cord injury (SCI) is a severe, disabling condition for which current treatments are largely insufficient in restoring neurological function. Despite advances in surgical and pharmacological interventions, no effective treatment currently exists to reverse neurological deficits caused by SCI. Mesenchymal stem cells (MSCs), especially human umbilical cord-derived MSCs (hucMSCs), have shown promise in tissue regeneration due to their multipotency and low immunogenicity.
View Article and Find Full Text PDFExercise-Activated Mesenchymal Stem Cells: A Translational Strategy for Age-Related Sarcopenia Management.
Stem Cell Rev Rep
September 2025
Key Laboratory of Physical Fitness and Exercise Rehabilitation of Hunan Province, College of Physical Education, Hunan Normal University, Changsha, 410012, China.
Age-related Sarcopenia is a progressive, age-related disorder characterized by the loss of muscle strength, mass, and function, which is associated with an increased risk of falls and mortality and reduced quality of life, particularly in older adults. The pathophysiology of sarcopenia is complex, primarily driven by an imbalance between anabolic and catabolic muscle homeostasis. Effective interventions of sarcopenia is crucial to reverse or delay the progression of muscle disorder.
View Article and Find Full Text PDFSynthesis of novel N1 functionalized diazepinone analogues a base-mediated C-N cross coupling reaction as reverse transcriptase inhibitors: theoretical and experimental investigations.
RSC Adv
August 2025
Department of Pharmacy Banasthali Vidyapith Banasthali Rajasthan India.
The sodium hydrogen orthophosphate (NaHPO) base was utilized in a stereospecific C-N coupling reaction to synthesize a novel series of nevirapine analogues in two-step reactions. This base is moisture tolerant, commercially available and makes the protocol cheap and energy efficient, with broad substrate tolerance, leading to the formation of cyclopropyl, cyclobutyl, cyclopentyl and propane-engrafted dipyridodiazepinone derivatives in good yield with a higher atom economy >70%. All the synthesized analogues were examined for reverse transcriptase inhibitory activity and compared with the reference drug nevirapine.
View Article and Find Full Text PDFReversible engraftment of an engineered microbe in the human gut.
Nat Biotechnol
August 2025
Nature Biotechnology, .
Alpha-enolase promotes progression of acute myeloid leukemia via MAPK/ERK signaling pathway.
Blood Sci
September 2025
Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian 116027, China.
Due to the limited availability of effective treatment therapies, patients with refractory and relapsed acute myeloid leukemia (AML) often have poor prognoses. Therefore, identifying new therapeutic targets to improve the treatment landscape and enhance AML outcomes is critical. In this study, we demonstrated for the first time that alpha-enolase (ENO1) is markedly overexpressed in AML and is closely associated with poor prognosis.
View Article and Find Full Text PDF